查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541099

2024-2032 年按产品、应用、最终用途和地区分類的病毒灭活市场报告

Viral Inactivation Market Report by Product, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球病毒灭活市场规模达6.356亿美元。

生物治疗产品含有病毒，或在生产过程中可能受到污染。病毒是侵入细胞的传染性颗粒，它们在细胞中增殖并导致各种疾病。因此，病毒灭活被广泛用于抑制病毒内的外壳蛋白和降解核酸。目前，根据病毒的特性和生物治疗产品的类型，全球范围内有不同的病毒灭活方法。例如，杀菌 (UVC) 光照射有助于灭活医院和其他重要公共和军事环境中的病毒。

病毒灭活市场趋势：

人体血液是有助于预防和治疗危及生命的疾病的药物的来源。人们越来越担心血源性病毒会透过血浆来源的药物传播，这是影响世界各地病毒灭活需求的重要因素之一。如今，使用多种病毒灭活程序来确保血浆来源的蛋白质溶液的安全性。此外，许多国家的管理机构在生物治疗产品开发的早期阶段就引入了严格的监管标准。这些标准不断提高对病毒灭活的需求，以确保这些产品的品质、安全性和有效性，从而降低交叉污染的风险。除此之外，食品和饮料（F&B）行业正在采用改进的病毒灭活技术和产品，以帮助控制肠病毒的传播并确保产品的安全。这与超临界流体、气体等离子体和脉衝电场等新物理方法的发展相结合，预计将提高病毒灭活的可靠性、便利性和适用性，从而推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球病毒灭活市场的表现如何，未来几年又将如何表现？
  • COVID-19 对全球病毒灭活市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于应用的市场区隔是什么？
  • 根据最终用途分類的市场是怎样的？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球病毒灭活市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球病毒灭活市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 试剂和试剂盒
    • 市场趋势
    • 市场预测
  • 系统
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 疫苗和治疗方法
    • 市场趋势
    • 市场预测
  • 干细胞产品
    • 市场趋势
    • 市场预测
  • 血液和血液製品
    • 市场趋势
    • 市场预测
  • 组织和组织产品
    • 市场趋势
    • 市场预测
  • 细胞和基因治疗
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：最终用途别

  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 合约研究组织
    • 市场趋势
    • 市场预测
  • 学术及研究机构
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Charles River Laboratories
    • Merck KGaA
    • Parker Hannifin Corp
    • Rad Source Technologies
    • Sartorius AG
    • SGS SA
    • Terumo Corporation
    • Texcell
    • Vironova AB
    • WuXi AppTec
Product Code: SR112024A4115

The global viral inactivation market size reached US$ 635.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,390.8 Million by 2032, exhibiting a growth rate (CAGR) of 8.8% during 2024-2032.

Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.

Viral Inactivation Market Trends:

Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.

Breakup by Product:

Reagents and Kits

Systems

Services

Breakup by Application:

Vaccines and Therapeutics

Stem Cell Products

Blood and Blood Products

Tissue and Tissue Products

Cellular and Gene Therapy

Breakup by End Use:

Pharmaceutical and Biotechnology Companies

CROs

Academic and Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.

Key Questions Answered in This Report:

  • How has the global viral inactivation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global viral inactivation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global viral inactivation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viral Inactivation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Vaccines and Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stem Cell Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood and Blood Products
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Tissue and Tissue Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cellular and Gene Therapy
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CROs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Merck KGaA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Parker Hannifin Corp
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Rad Source Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Sartorius AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 SGS SA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Terumo Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Texcell
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Vironova AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 WuXi AppTec
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
  • Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
  • Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
  • Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Viral Inactivation Market: Competitive Structure
  • Table 7: Global: Viral Inactivation Market: Key Players